Aegerion Pharmaceuticals, Inc. SEC Filings

Filed On	Filing
09 Aug 2019	SEC STAFF ACTION
08 Aug 2019	T-3/A
07 Aug 2019	CORRESP
30 Jul 2019	UPLOAD
18 Jul 2019	T-3
14 Feb 2017	SC 13G/A
14 Feb 2017	SC 13G/A
08 Feb 2017	SC 13G/A
31 Jan 2017	SCHEDULE 13G/A
12 Dec 2016	SC 13G/A
09 Dec 2016	15-12B
08 Dec 2016	EFFECT
05 Dec 2016	SCHEDULE 13G
01 Dec 2016	Form 4: Broadfin Healthcare Master Fund Ltd, 10% owner and 2 others Returned 4,361,291 shares to the issuer
01 Dec 2016	SC 13D/A
30 Nov 2016	Form 4: Plutzky Jorge Md, Director Disposed of 31,182 Stock Option (Right to Buy) (Disposition to Issuer)
30 Nov 2016	Form 4: Perry Gregory D, See Remarks Disposed of 509,000 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 35,000 Restricted Stock Units (Disposition to Issuer)
30 Nov 2016	Form 4: Louis Roger, Chief Compliance Officer Disposed of 102,000 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 8,000 Restricted Stock Units (Disposition to Issuer)
30 Nov 2016	Form 4: Harshbarger Benjamin, General Counsel and Secretary Returned 1,704 shares to the issuer · Disposed of 105,225 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 23,415 Restricted Stock Units (Disposition to Issuer)
30 Nov 2016	Form 4: Chan Barbara Y, VP, Chief Accounting Officer Disposed of 26,000 Stock Option (Right to Buy) (Disposition to Issuer)

Comments